Treatment with GLP-1 drugs must not replace obesity prevention in low and middle income countries. Buse K, Carriedo A, Barquera S. BMJ 2026;392:s407.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Buse K, Carriedo A, Barquera S. Treatment with GLP-1 drugs must not replace obesity prevention in low and middle income countries. BMJ 2026;392:s407.
PMID: 41771658